Schrodinger (NASDAQ:SDGR) Insider Sells $928,062.63 in Stock

Key Points

• Insider sale: Karen Akinsanya sold 31,599 Schrodinger shares for approximately $928,063 under a pre-arranged Rule 10b5-1 plan, reducing her ownership by 31.12% to 69,956 shares.
• Stock performance: Schrodinger shares rose 4.2% to $30.24, near the company’s 52-week high of $31.03, while trading volume exceeded its average.
• Mixed outlook: The company beat quarterly earnings and revenue expectations, but analysts maintain a consensus “Hold” rating with a $20.50 target price; institutional investors own 79.05% of the stock.

Schrodinger, Inc. (NASDAQ:SDGR - Get Free Report) insider Karen Akinsanya sold 31,599 shares of the business's stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $29.37, for a total transaction of $928,062.63. Following the sale, the insider owned 69,956 shares in the company, valued at $2,054,607.72. The trade was a 31.12% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Schrodinger Trading Up 4.2%

Shares of NASDAQ:SDGR traded up $1.22 on Monday, reaching $30.24. 2,887,620 shares of the company were exchanged, compared to its average volume of 1,403,211. The company has a 50-day moving average of $18.51 and a 200-day moving average of $15.20. The firm has a market cap of $2.23 billion, a price-to-earnings ratio of -40.86 and a beta of 1.69. Schrodinger, Inc. has a 1-year low of $10.94 and a 1-year high of $31.03.

Schrodinger (NASDAQ:SDGR - Get Free Report) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of ($0.41) by $0.49. Schrodinger had a negative net margin of 20.98% and a negative return on equity of 16.37%. The firm had revenue of $58.89 million during the quarter, compared to analysts' expectations of $47.19 million. During the same quarter last year, the business earned ($0.65) earnings per share. The business's revenue for the quarter was up 7.5% compared to the same quarter last year. As a group, analysts forecast that Schrodinger, Inc. will post -1.5 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on SDGR. Wall Street Zen upgraded Schrodinger from a "strong sell" rating to a "hold" rating in a report on Saturday, August 8th. Weiss Ratings raised Schrodinger from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, August 27th. Finally, UBS Group began coverage on Schrodinger in a research report on Friday, August 14th. They set a "neutral" rating and a $19.00 target price on the stock. Three analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $20.50.

Institutional Investors Weigh In On Schrodinger

Institutional investors and hedge funds have recently bought and sold shares of the stock. Integrated Wealth Concepts LLC acquired a new stake in Schrodinger during the 2nd quarter valued at $102,000. Squarepoint Ops LLC lifted its position in shares of Schrodinger by 290.4% in the second quarter. Squarepoint Ops LLC now owns 209,123 shares of the company's stock valued at $3,398,000 after acquiring an additional 155,556 shares in the last quarter. Allworth Financial LP lifted its position in shares of Schrodinger by 252.3% in the second quarter. Allworth Financial LP now owns 5,270 shares of the company's stock valued at $86,000 after acquiring an additional 3,774 shares in the last quarter. Corient Private Wealth LP acquired a new stake in shares of Schrodinger during the second quarter valued at $303,000. Finally, Beacon Pointe Advisors LLC acquired a new stake in shares of Schrodinger during the second quarter valued at $839,000. Hedge funds and other institutional investors own 79.05% of the company's stock.

Schrodinger Company Profile

Schrödinger, Inc develops computational software designed to accelerate drug discovery and materials science research. Its platform uses physics-based modeling, machine learning and related computational methods to help scientists analyze molecular structures, predict interactions and identify potential compounds for further development.

The company's software products support a range of research activities, including molecular modeling, virtual screening, structure-based drug design, free-energy calculations and collaborative data management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.